All assignments will be graded using marking rubrics.
Assessment 1 – Discussion Board Posts (15%)
Students will post weekly responses to discussion questions related to module content. They will be evaluated on both the quality of their post and their responses to their peers.
Assessment 2 – Case Study (40%)
In this multi-part assignment, students will be given a hypothetical case study. The case study will follow the patient’s journey from diagnosis. Students will be responsible for answering questions that will be used to evaluate their understanding of material covered throughout each section of the course. This assignment will prompt students to consider unique aspects of cancer progression and treatment specific to their assigned case study.
Assessment 3 – Multimedia Presentation (20%)
In this assignment, students will connect ideas learned in modules to study the molecular mechanisms relating regulatory B cells to malignant progression and metastasis. They will present their findings in a narrated powerpoint, and include research obtained from a primary paper.
Assessment 4 - Section Quiz (5%)
One quiz will be administered in the middle of the term. It will be in the form of multiple-choice questions and/or short answer questions that will test the student’s understanding of the material covered.
Assessment 5 - Final Exam (20%)
Students are required to write an online proctored final exam. The exam will include well-designed multiple choice and short-answer questions, with an emphasis on problem solving, that will test the students’ overall understanding and application of the course material, rather than rote memorization.